Azacitidine and Quizartinib for the Treatment of Myelodysplastic Syndrome or Myelodysplastic/Myeloproliferative Neoplasm With FLT3 or CBL Mutations
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Thomas Jefferson University
National Cancer Institute (NCI)
Roswell Park Cancer Institute
National Cancer Institute (NCI)
Fred Hutchinson Cancer Center
University of Manitoba
National Cancer Institute (NCI)
Case Comprehensive Cancer Center
University of Turin, Italy
Stanford University
Ohio State University Comprehensive Cancer Center
Hackensack Meridian Health
Dana-Farber Cancer Institute
City of Hope Medical Center
Massachusetts General Hospital
Assistance Publique - Hôpitaux de Paris
Takeda
Center for International Blood and Marrow Transplant Research
University of Washington
Memorial Sloan Kettering Cancer Center
Ohio State University Comprehensive Cancer Center
Jonsson Comprehensive Cancer Center
Fred Hutchinson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
City of Hope Medical Center
Massachusetts General Hospital
Novartis
M.D. Anderson Cancer Center
Mayo Clinic
University of Miami
Dartmouth-Hitchcock Medical Center
Children's Hospital Medical Center, Cincinnati
Memorial Sloan Kettering Cancer Center
Azienda Ospedaliero-Universitaria di Parma
Novartis
Center for International Blood and Marrow Transplant Research
City of Hope Medical Center
Dana-Farber Cancer Institute
MPN Research Foundation
Fred Hutchinson Cancer Center
Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
H. Lee Moffitt Cancer Center and Research Institute
H. Lee Moffitt Cancer Center and Research Institute
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center